Review
Prophylactic beta-blocker use to prevent perioperative morbidity and mortality
Affiliations
- PMID: 15490951
Item in Clipboard
Review
Prophylactic beta-blocker use to prevent perioperative morbidity and mortality
J S C Med Assoc.
2004 Aug.
Abstract
Cardiovascular disease continues to be a major health concern and leads to significant perioperative morbidity and mortality. Evidence for prophylactic use of beta-blockade to decrease these complications continues to grow. Not all patients benefit from perioperative beta-blockade, thus a thorough preoperative cardiac assessment should be performed with every patient undergoing surgery. Although physicians may have doubts with this new strategy, the literature overwhelmingly supports prophylactic beta-blockade use as a safe, efficacious, and cost effective new therapy in patients at risk for cardiac complications.
Similar articles
-
[Beta blockers reduce cardiac complications in patients undergoing surgery].Duodecim. 2000;116(17):1805-7. Duodecim. 2000. PMID: 12001633 Finnish. No abstract available.
-
The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.Am Heart J. 2004 Apr;147(4):677-83. doi: 10.1016/j.ahj.2003.10.030. Am Heart J. 2004. PMID: 15077084 Clinical Trial.
-
[Perioperative betablockade].Cas Lek Cesk. 2007;146(4):321-8. Cas Lek Cesk. 2007. PMID: 17491241 Review. Czech.
-
[Prophylactic perioperative beta-blockade reduces cardiac morbidity and mortality following non-cardiac surgery in patients at risk].Ned Tijdschr Geneeskd. 2004 Feb 7;148(6):268-75. Ned Tijdschr Geneeskd. 2004. PMID: 15004953 Review. Dutch.
-
Perioperative use of beta-blockers in the elderly patient.Anesthesiol Clin. 2009 Sep;27(3):581-97, table of contents. doi: 10.1016/j.anclin.2009.07.015. Anesthesiol Clin. 2009. PMID: 19825494 Review.